PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

Completed

Conditions: Hypertension

Registration Number: NCT00936208

Lead Sponsor: Boehringer Ingelheim

Brief Summary: PRO-POWER is an observational cohort study for a period of 24 weeks. All recruited patients will have essential hypertension. In addition, the patients will have at least one other contributing risk factor for cardiovascular events. The study aims to evaluate the safety, efficacy and protection of Micardis 80mg/Micardis plus 80/12.5mg from cardiovascular risks in patients with essential hypertension

Detailed Description: Not available

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 3184

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type: OBSERVATIONAL

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Diastolic Blood Pressure From Baseline at Week 24	Baseline and Week 24	The change from baseline reflects the week 24 value minus the baseline value.
Change in Systolic Blood Pressure From Baseline at Week 24	Baseline and Week 24	The change from baseline reflects the week 24 value minus the baseline value.

Secondary Outcome Measures

Name	Time	Method
Framingham Score at Week 24	Week 24	The Framingham score represent the cardiovascular risk and ranges from 0 (no risk) to 100% (complete risk).
Change in the Framingham Score From Baseline at Week 24	Baseline and Week 24	The change from baseline reflects the week 24 value minus the baseline value. The Framingham score represent the cardiovascular risk and ranges from 0 (no risk) to 100% (complete risk).
International Renal Interest Society (IRIS) II Score at Week 24	Week 24	The IRIS II score represent the risk for vascular complication in type to diabetes mellitus and ranges from 0 (no risk) to 100% (complete risk).
Change in the IRIS II Score From Baseline at Week 24	Baseline and Week 24	The change from baseline reflects the week 24 value minus the baseline value. The IRIS II score represent the risk for vascular complication in type to diabetes mellitus and ranges from 0 (no risk) to 100% (complete risk).
Change From Baseline in Urinary Microalbuminuria (Urine Dipstick Test Results)	Baseline and Week 24	The change from baseline reflects the shift from baseline in urinary dipstick test results to week 24

Trial Locations

Locations (120): Boehringer Ingelheim Investigational Site 16
🇪🇬
Alexandria West, Egypt
Boehringer Ingelheim Investigational Site 21
🇪🇬
Alexandria, Egypt
Boehringer Ingelheim Investigational Site 12
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 28
🇪🇬
Fayoum, Egypt
Boehringer Ingelheim Investigational Site 94
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 35
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 40
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 38
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 45
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 48
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 55
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 60
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 33
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 43
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 46
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 50
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 51
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 57
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 58
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 84
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 104
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 106
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 108
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 111
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 20
🇪🇬
Alexandria, Egypt
Boehringer Ingelheim Investigational Site 29
🇪🇬
Assiut, Egypt
Boehringer Ingelheim Investigational Site 10
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 11
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 1
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 3
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 4
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 5
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 6
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 8
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 9
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 25
🇪🇬
Fakous - El Sharkia, Egypt
Boehringer Ingelheim Investigational Site 15
🇪🇬
El Minia, Egypt
Boehringer Ingelheim Investigational Site 24
🇪🇬
Poert said, Egypt
Boehringer Ingelheim Investigational Site 26
🇪🇬
Zagazig - El Sharkia, Egypt
Boehringer Ingelheim Investigational Site 101
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 92
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 93
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 97
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 98
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 96
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 99
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 31
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 36
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 37
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 34
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 30
🇪🇬
Menofia, Egypt
Boehringer Ingelheim Investigational Site 95
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 42
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 49
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 52
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 59
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 63
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 70
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 74
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 77
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 27
🇪🇬
Mansoura - El Dakahlia, Egypt
Boehringer Ingelheim Investigational Site 32
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 2
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 7
🇪🇬
Cairo, Egypt
Boehringer Ingelheim Investigational Site 23
🇪🇬
El Garbia, Egypt
Boehringer Ingelheim Investigational Site 14
🇪🇬
El Minia, Egypt
Boehringer Ingelheim Investigational Site 13
🇪🇬
Kalioubya, Egypt
Boehringer Ingelheim Investigational Site 39
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 44
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 47
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 53
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 61
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 62
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 66
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 67
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 75
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 80
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 81
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 82
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 88
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 90
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 116
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 120
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 17
🇪🇬
Alexandria West, Egypt
Boehringer Ingelheim Investigational Site 100
🇸🇦
Eastern Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 41
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 56
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 68
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 83
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 85
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 87
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 91
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 114
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 107
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 110
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 18
🇪🇬
Alexandria, Egypt
Boehringer Ingelheim Investigational Site 19
🇪🇬
Alexandria, Egypt
Boehringer Ingelheim Investigational Site 22
🇪🇬
Domiat, Egypt
Boehringer Ingelheim Investigational Site 54
🇸🇦
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site 64
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 65
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 71
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 72
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 73
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 76
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 78
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 79
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 117
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 119
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 102
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 103
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 109
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 69
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 86
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 115
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 105
🇦🇪
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site 89
🇸🇦
Western Region, Saudi Arabia
Boehringer Ingelheim Investigational Site 113
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 118
🇦🇪
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site 112
🇦🇪
Sharjah, United Arab Emirates